MA55719A - Procédé de traitement du syndrome de sevrage des opioïdes néonatal - Google Patents

Procédé de traitement du syndrome de sevrage des opioïdes néonatal

Info

Publication number
MA55719A
MA55719A MA055719A MA55719A MA55719A MA 55719 A MA55719 A MA 55719A MA 055719 A MA055719 A MA 055719A MA 55719 A MA55719 A MA 55719A MA 55719 A MA55719 A MA 55719A
Authority
MA
Morocco
Prior art keywords
withdrawal syndrome
opioid withdrawal
treating neonatal
neonatal opioid
treating
Prior art date
Application number
MA055719A
Other languages
English (en)
Inventor
Massimo Cella
Walter Karl Kraft
Merran Ann Thomson
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MA55719A publication Critical patent/MA55719A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA055719A 2019-04-18 2020-04-17 Procédé de traitement du syndrome de sevrage des opioïdes néonatal MA55719A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962835711P 2019-04-18 2019-04-18

Publications (1)

Publication Number Publication Date
MA55719A true MA55719A (fr) 2022-02-23

Family

ID=70470980

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055719A MA55719A (fr) 2019-04-18 2020-04-17 Procédé de traitement du syndrome de sevrage des opioïdes néonatal

Country Status (11)

Country Link
US (1) US20200330455A1 (fr)
EP (1) EP3955888A1 (fr)
JP (1) JP2022529773A (fr)
KR (1) KR20220003541A (fr)
CN (1) CN114007587A (fr)
AU (1) AU2020259128A1 (fr)
BR (1) BR112021019901A2 (fr)
CA (1) CA3136028A1 (fr)
MA (1) MA55719A (fr)
MX (1) MX2021012577A (fr)
WO (1) WO2020212549A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023003810A1 (fr) * 2021-07-18 2023-01-26 Case Western Reserve University Compositions et méthodes de traitement de la dépendance et du sevrage d'opioïdes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8533582A (en) * 1981-07-10 1984-01-12 Reckitt & Colman Products Limited Stable solutions of buprenorphine
EP1897543A1 (fr) * 2006-08-30 2008-03-12 Euro-Celtique S.A. Gaufre de buprénorphine pour la thérapie de substitution
WO2009126931A2 (fr) * 2008-04-11 2009-10-15 Xvasive, Inc. Thérapie combinatoire pour trouble bipolaire
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
PL2915525T3 (pl) * 2011-09-19 2022-01-17 Orexo Ab Tabletki podjęzykowe niepodatne na nadużywanie zawierające buprenorfinę i nalokson
WO2016105563A1 (fr) * 2014-12-23 2016-06-30 Arx, Llc Procédé de production de formulations uniformes contenant de la buprénorphine
EP3697381B1 (fr) * 2017-10-20 2023-06-07 Chiesi Farmaceutici S.p.A. Formulations pharmaceutiques comprenant des agonistes de récepteurs opioïdes comme ingrédients actifs, leurs procédés de fabrication et leurs utilisations thérapeutiques

Also Published As

Publication number Publication date
EP3955888A1 (fr) 2022-02-23
WO2020212549A1 (fr) 2020-10-22
US20200330455A1 (en) 2020-10-22
JP2022529773A (ja) 2022-06-24
MX2021012577A (es) 2021-11-12
CN114007587A (zh) 2022-02-01
KR20220003541A (ko) 2022-01-10
BR112021019901A2 (pt) 2022-02-15
CA3136028A1 (fr) 2020-10-22
AU2020259128A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
HK1248671A1 (zh) 處理水的方法和設備
HK1257877A1 (zh) 可處理聚乙烯醇的生產工藝和設備
FR2990360B1 (fr) Procede de traitement de gaz
ZA201800327B (en) Effluent treatment process ¿ ph refinement for sulphate removal
ZA201601638B (en) Method of treating a pickling solution for a pickling process
MA41941A (fr) Procédé de purification de protéines
FR2975899B1 (fr) Procede de traitement des fibres keratiniques defrisees
MA43944A (fr) Procédé de purification de liquide
PT3535257T (pt) Processo para a purificação de pirazolpiridazinas
MA42936A (fr) Procédé de traitement de blessures cardiaques
GB202101114D0 (en) PROCESS FOR mRNA PURIFICATION
MA50349A (fr) Procédé de traitement de tôle métallique et tôle métallique traitée avec ce procédé
ZA201800325B (en) Improved effluent treatment process for sulphate removal
MA55719A (fr) Procédé de traitement du syndrome de sevrage des opioïdes néonatal
PT3899113T (pt) Processo para o tratamento de fibras de lyocell
DE112015002699A5 (de) Verfahren und Vorrichtung zum Abziehen und Verstrecken mehrerer frisch gesponnener Fäden
MA50350A (fr) Procédé de traitement de feuille métallique et feuille métallique traitée par ce procédé
SG11201802755WA (en) Process for purification of methyl methacrylate
MA49688A (fr) Procédés de traitement du syndrome myélodysplasique
FR3021184B1 (fr) Procede de traitement de semences
FR3035795B1 (fr) Procede de traitement de gaz
EP2981259A4 (fr) Composition pour traiter la neuropathie, son processus et son procédé de traitement
FR3003185B1 (fr) Procede de traitement d'un reacteur catalytique
MA54852A (fr) Procédé de purification de cystéamine
MA56499A (fr) Procédé de préparation de solutions radioactives